Irregularities In COVID Reporting Contract Award Process Raises New Questions
By Dina Temple-Raston & Tim Mak,
NPR
| 07. 29. 2020
An NPR investigation has found irregularities in the process by which the Trump administration awarded a multi-million dollar contract to a Pittsburgh company to collect key data about COVID-19 from the country's hospitals.
The contract is at the center of a controversy over the administration's decision to move that data reporting function from the Centers for Disease Control and Prevention — which has tracked infection information for a range of illnesses for years — to the Department of Health and Human Services.
TeleTracking Technologies, the company that won the contract, has traditionally focused on creating software for hospitals to track patient status. And there are questions about how it came to be responsible for gathering data in the midst of a pandemic.
Among the findings of the NPR investigation:
- The Department of Health and Human Services initially characterized the contract with TeleTracking as a no-bid contract. When asked about that, HHS said there was a "coding error" and that the contract was actually competitively bid.
- The process by which HHS awarded the contract is normally used for innovative scientific research,...
see more
Related Articles
As the November 3 election approaches, Californians are focusing on the ballot propositions. The money spent on them this year is not only record-breaking, it’s almost unbelievable: more than $700 million so far, for and against a dozen measures.
In that context, spending by the campaign for Proposition 14, to fund the California Institute for Regenerative Medicine again, seems almost modest. As of October 17, according to the informative Ballotpedia page, proponents have raised over $16 million (including...
By Jude Casimir, Wear Your Voice [cites CGS' Marcy Darnovsky] | 10.27.2020
Henrietta Lacks visited John Hopkins Hospital in 1951, complaining of vaginal bleeding. A mother of five children, Lacks was diagnosed by gynecologist Howard Jones with cervical cancer. After undergoing radium treatments, sample cells were extracted from her tumor. While the cells extracted...
By Usha Lee McFarling, STAT | 10.26.2020
LOS ANGELES — This Election Day, California voters are being asked to replenish funding for the state’s ambitious stem cell research program, with a well-financed campaign that’s making heady promises about curing diabetes, paralysis, cancer, and Parkinson’s and Alzheimer’s diseases....
By Françoise Baylis, Marcy Darnovsky, Katie Hasson, and Timothy M. Krahn, The CRISPR Journal | 10.20.2020
Abstract
Discussions and debates about the governance of human germline and heritable genome editing should be informed by a clear and accurate understanding of the global policy landscape. This policy survey of 106 countries yields significant new data. A large...
